Dashboard
LoginSign Up

Financial News

benzinga109d ago

CLIQ Reports Full Year 2025 Results

Severe market conditions impact sales (down 46% y/y to €132m)EBITDA down 163% y/y to -€6m-€2.13 EPS resulting from €12m loss in the financial yearDÜSSELDORF, 5 March 2025 – The CLIQ Group publishes today its audited 2025 financial statements. The Annual Report 2025 is available on the Group's website at https://cliqdigital.com/investors/financials.As previously announced, CLIQ has optimised its financial reporting by focusing on the mandatory annual and half-year financial statements and publications instead of quarterly financial reports and earnings calls. In line with statutory requirements, the Annual Report 2025 has been prepared and published in German as the legally required language.A summarised income statement, balance sheet and cash flow overview shown here:Income Statement in millions of €4Q 20253Q 2025Δ FY 2025FY 2024ΔSales12.321.5-43% 131.9243.0-46%CAC for the period-5.7-14.4 -52.7-97.1 Cost of sales (ex CAC for the period)-5.8-8.3 -57.6-100.3 Operating expenses-4.9-7.6 -28.1-35.5 EBITDA -4.1-8.753% -6.410.2-163%Margin-34%-41% -5%4% Depreciation & amortisation-2.0-1.8 -7.3-34.9 EBIT-6.2-10.542% Full story available on Benzinga.com

#STOCKS
Kenya Pipeline Company IPO Results: What this Means for NSE and Investors
businesstoday_co_ke109d ago

Kenya Pipeline Company IPO Results: What this Means for NSE and Investors

Kenya Pipeline Company (KPC) IPO results have now been published, marking a watershed moment for the Nairobi Securities Exchange(NSE) and Kenya’s capital markets. After an extended offer period, the Kenya Pipeline Company public subscription closed with a 105% subscription rate, meaning there was more demand than shares available, with over 12 billion shares applied for across [...]

#STOCKS
23% YTD return: Logistics stock jumps over 4% as markets bounce back amid positive global cues
indiatvnews109d ago

23% YTD return: Logistics stock jumps over 4% as markets bounce back amid positive global cues

Shares of Sindhu Trade Links Ltd, a smallcap company in the logistics sector with a market capitalisation of Rs 3,760.76 crore, witnessed a strong rise on Thursday as markets bounced back amid positive global cues, after facing heavy losses in the past few trading sessions due to the conflict in West Asia. The counter started the trading session in the green at Rs 24.17 against the previous close of Rs 23.30. Last seen, the stock was trading at Rs 24.39 on the BSE, up 4.68 per cent or Rs 1.09. On the National Stock Exchange (NSE), the stock was trading at Rs 24.41, up 4.32 per cent or Rs 1.01. In between, the stock touched intraday highs and lows of Rs 24.51 and Rs 23.97, respectively.

#STOCKS
Celestica (TSE:CLS) Stock Crosses Below 200-Day Moving Average – Time to Sell?
americanbankingnews109d ago

Celestica (TSE:CLS) Stock Crosses Below 200-Day Moving Average – Time to Sell?

Shares of Celestica Inc. (TSE:CLS – Get Free Report) (NYSE:CLS) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$392.39 and traded as low as C$352.83. Celestica shares last traded at C$369.19, with a volume of 384,596 shares. Wall Street Analyst Weigh In Several brokerages [...]

#STOCKS
Symphony Environmental Technologies (LON:SYM) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?
americanbankingnews109d ago

Symphony Environmental Technologies (LON:SYM) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?

Symphony Environmental Technologies plc (LON:SYM – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 8.56 and traded as low as GBX 7. Symphony Environmental Technologies shares last traded at GBX 7.75, with a volume of 31,901 shares traded. [...]

#STOCKS
Royal Bank Of Canada Boosts Intellia Therapeutics (NASDAQ:NTLA) Price Target to $15.00
americanbankingnews109d ago

Royal Bank Of Canada Boosts Intellia Therapeutics (NASDAQ:NTLA) Price Target to $15.00

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) had its target price raised by equities researchers at Royal Bank Of Canada from $9.00 to $15.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s price objective indicates a potential upside of 8.54% [...]

#STOCKS